Cargando…

Reporting of Drug Expenditures in the MCBS

Comparing data from both the 1999 MCBS and drug utilization data supplied by the survey respondents' pharmacies, the author details the methods used to determine the level of misreporting of drug expenditures in the MCBS. Findings suggest that prescription drug expenditures are underreported by...

Descripción completa

Detalles Bibliográficos
Autor principal: Poisal, John A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: CENTERS for MEDICARE & MEDICAID SERVICES 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194806/
https://www.ncbi.nlm.nih.gov/pubmed/15124375
_version_ 1782339190642442240
author Poisal, John A.
author_facet Poisal, John A.
author_sort Poisal, John A.
collection PubMed
description Comparing data from both the 1999 MCBS and drug utilization data supplied by the survey respondents' pharmacies, the author details the methods used to determine the level of misreporting of drug expenditures in the MCBS. Findings suggest that prescription drug expenditures are underreported by 17 percent and the number of prescriptions used is underreported by 17.7 percent. The data also identify demographic factors that predict a beneficiary's likelihood to either overreport or underreport his or her medications, as well as the extent to which beneficiaries misreport their drug use and spending.
format Online
Article
Text
id pubmed-4194806
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher CENTERS for MEDICARE & MEDICAID SERVICES
record_format MEDLINE/PubMed
spelling pubmed-41948062014-11-04 Reporting of Drug Expenditures in the MCBS Poisal, John A. Health Care Financ Rev Research Article Comparing data from both the 1999 MCBS and drug utilization data supplied by the survey respondents' pharmacies, the author details the methods used to determine the level of misreporting of drug expenditures in the MCBS. Findings suggest that prescription drug expenditures are underreported by 17 percent and the number of prescriptions used is underreported by 17.7 percent. The data also identify demographic factors that predict a beneficiary's likelihood to either overreport or underreport his or her medications, as well as the extent to which beneficiaries misreport their drug use and spending. CENTERS for MEDICARE & MEDICAID SERVICES 2003 /pmc/articles/PMC4194806/ /pubmed/15124375 Text en
spellingShingle Research Article
Poisal, John A.
Reporting of Drug Expenditures in the MCBS
title Reporting of Drug Expenditures in the MCBS
title_full Reporting of Drug Expenditures in the MCBS
title_fullStr Reporting of Drug Expenditures in the MCBS
title_full_unstemmed Reporting of Drug Expenditures in the MCBS
title_short Reporting of Drug Expenditures in the MCBS
title_sort reporting of drug expenditures in the mcbs
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194806/
https://www.ncbi.nlm.nih.gov/pubmed/15124375
work_keys_str_mv AT poisaljohna reportingofdrugexpendituresinthemcbs